SKIN PROTECTANT

SKIN PROTECTANT was reported 2676 times

SKIN PROTECTANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 148 0.4884
1 AMYLOID ARTHROPATHY 29 0.4143
2 PSEUDOHYPOPYON 4 0.3333
3 TRANSFERRIN SATURATION ABNORMAL 5 0.2941
4 CARBOHYDRATE ANTIGEN 15-3 3 0.1000
5 FEMALE GENITAL TRACT FISTULA 159 0.0930
6 TOTAL LUNG CAPACITY INCREASED 23 0.0846
7 CARBUNCLE 23 0.0813
8 PRODUCT ADMINISTRATION ISSUE 14 0.0670
9 ANAL INFLAMMATION 38 0.0595
10 RADICULOPATHY 154 0.0584
11 PROCTITIS 148 0.0528
12 CHRONIC SINUSITIS 198 0.0527
13 SARS-COV-2 TEST NEGATIVE 33 0.0489
14 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 23 0.0440
15 MACULAR DEGENERATION 460 0.0385
16 ASYMPTOMATIC BACTERIURIA 5 0.0368
17 DUODENAL NEOPLASM 3 0.0306
18 MONOCLONAL IMMUNOGLOBULIN PRESENT 22 0.0289
19 ANAL EROSION 3 0.0273
20 WRIST DEFORMITY 15 0.0244
21 DERMATOPHYTOSIS 6 0.0211
22 GLOMERULONEPHRITIS CHRONIC 3 0.0160
23 SERUM FERRITIN ABNORMAL 5 0.0156
24 FAMILIAL MEDITERRANEAN FEVER 3 0.0153
25 HYPOTHALAMO-PITUITARY DISORDER 22 0.0151
26 GASTROSTOMY TUBE SITE COMPLICATION 3 0.0150
27 VAGINAL DISCHARGE 149 0.0147
28 PARAESTHESIA ORAL 198 0.0137
29 MIGRAINE WITHOUT AURA 4 0.0133
30 NEUROBLASTOMA 5 0.0131
31 ORAL CANDIDIASIS 150 0.0114
32 MENINGOENCEPHALITIS HERPETIC 5 0.0112
33 CREATININE RENAL CLEARANCE ABNORMAL 5 0.0108
34 PULMONARY PAIN 31 0.0106
35 FEEDING INTOLERANCE 4 0.0089
36 PROCTALGIA 57 0.0089
37 DERMATITIS DIAPER 6 0.0085
38 GINGIVAL ERYTHEMA 7 0.0081
39 TYPE III IMMUNE COMPLEX MEDIATED REACTION 4 0.0072
40 FIBROSIS 22 0.0071
41 ALVEOLAR OSTEITIS 3 0.0071
42 JARISCH-HERXHEIMER REACTION 5 0.0070
43 PROCEDURAL PAIN 190 0.0068
44 JAUNDICE CHOLESTATIC 24 0.0068
45 PNEUMONIA STREPTOCOCCAL 7 0.0064
46 INJECTION SITE ULCER 6 0.0064
47 TINEA INFECTION 7 0.0063
48 HYPOMANIA 23 0.0062
49 RHINITIS ALLERGIC 27 0.0061
50 SEPSIS SYNDROME 3 0.0060
51 SKIN CANDIDA 3 0.0057
52 FREQUENT BOWEL MOVEMENTS 153 0.0057
53 XEROSIS 7 0.0057
54 LIP EROSION 4 0.0055
55 LIFE EXPECTANCY SHORTENED 3 0.0053
56 NASAL POLYPS 26 0.0053
57 AORTIC CALCIFICATION 3 0.0052
58 UPPER RESPIRATORY TRACT INFLAMMATION 6 0.0050
59 PSEUDOMONAS TEST POSITIVE 4 0.0049
60 SARCOIDOSIS 23 0.0048
61 ENTEROVIRUS INFECTION 4 0.0046
62 FINGER DEFORMITY 22 0.0045
63 DYSLIPIDAEMIA 23 0.0045
64 CANDIDA SEPSIS 4 0.0045
65 LICHEN SCLEROSUS 3 0.0044
66 CERUMEN IMPACTION 4 0.0044
67 LEIOMYOMA 3 0.0043
68 COLITIS 161 0.0042
69 LANGUAGE DISORDER 9 0.0042
70 OVERWEIGHT 22 0.0041
71 BRONCHIECTASIS 26 0.0039
72 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 3 0.0038
73 MUSCLE DISCOMFORT 3 0.0038
74 RECTAL HAEMORRHAGE 163 0.0038
75 BRONCHOPULMONARY DYSPLASIA 3 0.0037
76 DYSBIOSIS 3 0.0037
77 GRANULOMA SKIN 3 0.0037
78 SEPTIC EMBOLUS 3 0.0036
79 RENAL CYST 28 0.0035
80 COLITIS ULCERATIVE 154 0.0034
81 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 3 0.0032
82 HYPOPROTEINAEMIA 6 0.0032
83 KLEBSIELLA BACTERAEMIA 3 0.0032
84 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 222 0.0031
85 HAEMATOCHEZIA 172 0.0031
86 INFUSION RELATED REACTION 206 0.0031
87 ACCIDENT 36 0.0030
88 CARDIAC MURMUR 26 0.0030
89 PURPURA 26 0.0029
90 KIDNEY FIBROSIS 5 0.0029
91 DECUBITUS ULCER 23 0.0028
92 NEPHROPATHY 26 0.0028
93 IMPETIGO 4 0.0027
94 APLASTIC ANAEMIA 14 0.0027
95 DYSAESTHESIA 8 0.0026
96 PERIPHERAL EMBOLISM 3 0.0026
97 RHINOVIRUS INFECTION 10 0.0026
98 BICYTOPENIA 5 0.0025
99 CHRONIC RESPIRATORY FAILURE 3 0.0025
100 DEVICE RELATED SEPSIS 5 0.0025
101 SKIN EROSION 8 0.0025
102 MONOCYTE COUNT DECREASED 3 0.0025
103 VASCULAR DEVICE INFECTION 11 0.0024
104 THERAPEUTIC PRODUCT EFFECT DELAYED 11 0.0024
105 NEUROGENIC BLADDER 5 0.0024
106 LUNG NEOPLASM 10 0.0023
107 BODY HEIGHT DECREASED 25 0.0023
108 MEAN CELL VOLUME INCREASED 6 0.0023
109 PLATELET TRANSFUSION 3 0.0023
110 ACUTE SINUSITIS 4 0.0023
111 MESOTHELIOMA 3 0.0023
112 BACTERIAL TEST POSITIVE 5 0.0022
113 HAEMORRHOIDS 43 0.0022
114 PNEUMONIA VIRAL 7 0.0022
115 RHONCHI 3 0.0022
116 DYSPEPSIA 210 0.0021
117 PUSTULE 5 0.0021
118 VOLVULUS 5 0.0021
119 BODY TEMPERATURE INCREASED 42 0.0021
120 SCHIZOPHRENIA 25 0.0021
121 ILEUS PARALYTIC 9 0.0020
122 BRONCHIOLITIS 7 0.0020
123 PEMPHIGOID 15 0.0020
124 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
125 PARAINFLUENZAE VIRUS INFECTION 3 0.0020
126 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
127 CANCER PAIN 5 0.0020
128 OVARIAN CANCER RECURRENT 3 0.0019
129 PERIODONTITIS 4 0.0018
130 OBESITY 29 0.0018
131 CLOSTRIDIUM TEST POSITIVE 4 0.0018
132 CHOLELITHIASIS 59 0.0018
133 EROSIVE OESOPHAGITIS 3 0.0018
134 BACTERAEMIA 21 0.0018
135 SCIATICA 28 0.0018
136 GRANULOMA 6 0.0017
137 GASTROINTESTINAL NECROSIS 5 0.0017
138 JOINT RANGE OF MOTION DECREASED 23 0.0017
139 DISCOURAGEMENT 4 0.0017
140 FANCONI SYNDROME ACQUIRED 3 0.0017
141 FEBRILE NEUTROPENIA 113 0.0017
142 ESCHERICHIA BACTERAEMIA 4 0.0017
143 MALNUTRITION 19 0.0017
144 PULMONARY TOXICITY 12 0.0017
145 SPINAL COMPRESSION FRACTURE 14 0.0017
146 PNEUMONIA ASPIRATION 42 0.0017
147 METABOLIC ENCEPHALOPATHY 5 0.0017
148 DISSEMINATED INTRAVASCULAR COAGULATION 23 0.0016
149 DERMAL CYST 4 0.0016
150 HYPERNATRAEMIA 8 0.0016
151 HYPERPARATHYROIDISM SECONDARY 4 0.0016
152 CATHETER SITE INFECTION 6 0.0016
153 CUSHINGOID 5 0.0016
154 LUNG OPACITY 4 0.0015
155 HEPATIC STEATOSIS 28 0.0015
156 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
157 MUCOSAL DRYNESS 3 0.0015
158 METASTASES TO SPINE 5 0.0015
159 SKIN DISCOMFORT 4 0.0015
160 DERMATITIS ACNEIFORM 9 0.0015
161 IMMUNE-MEDIATED HEPATITIS 3 0.0015
162 BLOOD BILIRUBIN INCREASED 39 0.0014
163 HEPATOTOXICITY 32 0.0014
164 PNEUMONIA BACTERIAL 13 0.0014
165 DRUG ERUPTION 25 0.0014
166 HAEMORRHAGE SUBCUTANEOUS 5 0.0014
167 CATHETER SITE ERYTHEMA 3 0.0014
168 HYPERPHOSPHATAEMIA 3 0.0014
169 SYNOVITIS 25 0.0014
170 ENTEROCOLITIS 8 0.0014
171 HAEMOTHORAX 4 0.0014
172 RALES 8 0.0014
173 PARONYCHIA 6 0.0014
174 NOSOCOMIAL INFECTION 3 0.0014
175 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
176 FOOT DEFORMITY 15 0.0014
177 HEPATITIS FULMINANT 4 0.0013
178 PSEUDOMEMBRANOUS COLITIS 3 0.0013
179 CHRONIC GASTRITIS 3 0.0013
180 MYELOFIBROSIS 4 0.0013
181 REBOUND ACID HYPERSECRETION 4 0.0013
182 RECTAL CANCER 4 0.0013
183 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
184 NEPHROGENIC ANAEMIA 6 0.0013
185 ILEUS 16 0.0013
186 HYPOALBUMINAEMIA 10 0.0013
187 PSEUDOMONAS INFECTION 11 0.0013
188 PULMONARY INFARCTION 3 0.0013
189 ABDOMINAL ADHESIONS 4 0.0013
190 ANAEMIA 241 0.0013
191 LIMB INJURY 34 0.0013
192 LYMPHADENITIS 3 0.0012
193 HYPERAMMONAEMIA 6 0.0012
194 KNEE ARTHROPLASTY 25 0.0012
195 INCREASED BRONCHIAL SECRETION 3 0.0012
196 PUSTULAR PSORIASIS 4 0.0012
197 PYREXIA 400 0.0012
198 FAILURE TO THRIVE 6 0.0012
199 THROMBOPHLEBITIS 4 0.0011
200 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
201 BREAST SWELLING 3 0.0011
202 CHRONIC GRAFT VERSUS HOST DISEASE 4 0.0011
203 EAR CONGESTION 3 0.0011
204 GASTRIC PERFORATION 3 0.0011
205 HYDROCEPHALUS 6 0.0011
206 CONSTIPATION 240 0.0011
207 BLOOD PHOSPHORUS INCREASED 3 0.0011
208 HAEMOGLOBIN ABNORMAL 7 0.0011
209 IMMUNE-MEDIATED ENTEROCOLITIS 4 0.0011
210 HYPOPHOSPHATAEMIA 8 0.0011
211 MACULE 3 0.0011
212 ABDOMINAL PAIN 251 0.0011
213 LUNG CONSOLIDATION 3 0.0011
214 SKIN HYPERTROPHY 3 0.0011
215 PNEUMATOSIS INTESTINALIS 3 0.0011
216 DERMATITIS 22 0.0010
217 DUODENAL ULCER HAEMORRHAGE 3 0.0010
218 LIP PAIN 3 0.0010
219 DEVICE RELATED INFECTION 16 0.0010
220 ATELECTASIS 10 0.0010
221 PNEUMONIA FUNGAL 4 0.0010
222 HYPERVOLAEMIA 5 0.0010
223 ARTHROPATHY 56 0.0010
224 AZOTAEMIA 4 0.0010
225 MOVEMENT DISORDER 32 0.0010
226 JOINT STIFFNESS 26 0.0010
227 FUNGAL SKIN INFECTION 4 0.0010
228 MASTICATION DISORDER 3 0.0010
229 HYPERURICAEMIA 4 0.0010
230 CACHEXIA 5 0.0010
231 PERIPHERAL VASCULAR DISORDER 5 0.0010
232 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
233 CHOLANGITIS 6 0.0010
234 WEIGHT DECREASED 270 0.0010
235 OLIGURIA 6 0.0010
236 SEPTIC SHOCK 42 0.0010
237 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
238 DYSSTASIA 28 0.0010
239 BLOOD CREATININE DECREASED 3 0.0010
240 ELECTROLYTE IMBALANCE 11 0.0009
241 ERYTHEMA 193 0.0009
242 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
243 COVID-19 PNEUMONIA 11 0.0009
244 BACTERIAL SEPSIS 3 0.0009
245 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
246 HEPATIC NEOPLASM 3 0.0009
247 DIVERTICULUM INTESTINAL 4 0.0009
248 HYPOGAMMAGLOBULINAEMIA 6 0.0009
249 ONYCHOMYCOSIS 4 0.0009
250 HAEMORRHAGIC ANAEMIA 4 0.0009
251 HYPOXIA 32 0.0009
252 OTITIS MEDIA 3 0.0009
253 INTESTINAL ISCHAEMIA 5 0.0009
254 CONGENITAL ANOMALY 7 0.0009
255 CARDIAC FAILURE ACUTE 6 0.0009
256 NEPHRITIS 3 0.0009
257 SKIN INFECTION 10 0.0009
258 HEPATIC CYST 3 0.0009
259 HEPATIC ENZYME INCREASED 60 0.0009
260 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
261 IRON DEFICIENCY ANAEMIA 8 0.0009
262 MYASTHENIA GRAVIS 7 0.0009
263 BLOOD URIC ACID INCREASED 5 0.0009
264 ERYTHEMA MULTIFORME 8 0.0009
265 ARTERIOSCLEROSIS 8 0.0008
266 DECREASED INTEREST 5 0.0008
267 HAEMORRHAGIC DIATHESIS 3 0.0008
268 EOSINOPHIL COUNT INCREASED 7 0.0008
269 LOWER RESPIRATORY TRACT INFECTION 38 0.0008
270 SUBCUTANEOUS ABSCESS 4 0.0008
271 LIVER DISORDER 37 0.0008
272 HEPATIC FUNCTION ABNORMAL 31 0.0008
273 MONOCYTE COUNT INCREASED 3 0.0008
274 FOETAL GROWTH RESTRICTION 5 0.0008
275 CUTANEOUS VASCULITIS 3 0.0008
276 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0008
277 ANURIA 7 0.0008
278 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
279 SKIN DISORDER 27 0.0008
280 ORGANISING PNEUMONIA 4 0.0008
281 LEUKOENCEPHALOPATHY 3 0.0008
282 OSTEOPOROSIS 33 0.0008
283 PROTEIN TOTAL DECREASED 3 0.0008
284 CORONARY ARTERY STENOSIS 4 0.0008
285 PARANASAL SINUS DISCOMFORT 3 0.0008
286 LYMPHOCYTE COUNT DECREASED 14 0.0008
287 FACE INJURY 3 0.0008
288 DERMATITIS CONTACT 9 0.0008
289 SCAB 9 0.0008
290 GASTRIC INFECTION 3 0.0008
291 RENAL FAILURE CHRONIC 6 0.0008
292 PSYCHOTIC DISORDER 23 0.0008
293 VARICOSE VEIN 4 0.0008
294 SEPSIS 86 0.0008
295 PULMONARY HAEMORRHAGE 6 0.0008
296 BONE DENSITY DECREASED 24 0.0008
297 BLOOD ALBUMIN DECREASED 6 0.0008
298 CORONAVIRUS INFECTION 5 0.0008
299 OSTEOARTHRITIS 32 0.0008
300 RESPIRATORY FAILURE 55 0.0008
301 GASTROENTERITIS 11 0.0008
302 HYPERLIPIDAEMIA 9 0.0008
303 CEREBRAL ATROPHY 3 0.0008
304 HEPATIC ENCEPHALOPATHY 7 0.0007
305 BLEPHARITIS 3 0.0007
306 CYTOKINE RELEASE SYNDROME 15 0.0007
307 ANAL FISSURE 4 0.0007
308 CYSTITIS HAEMORRHAGIC 3 0.0007
309 ADRENAL INSUFFICIENCY 9 0.0007
310 HYPOKALAEMIA 34 0.0007
311 RECURRENT CANCER 3 0.0007
312 OESOPHAGITIS 8 0.0007
313 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
314 ASPIRATION 8 0.0007
315 ECCHYMOSIS 5 0.0007
316 HYPERCALCAEMIA 9 0.0007
317 PLEURAL EFFUSION 44 0.0007
318 MALAISE 317 0.0007
319 GASTRIC ULCER HAEMORRHAGE 4 0.0007
320 STEVENS-JOHNSON SYNDROME 16 0.0007
321 PSORIATIC ARTHROPATHY 29 0.0007
322 RENAL TUBULAR NECROSIS 7 0.0007
323 HYPERKALAEMIA 25 0.0007
324 ACUTE PULMONARY OEDEMA 4 0.0007
325 PAPULE 5 0.0007
326 THERMAL BURN 5 0.0007
327 CARDIAC FAILURE CHRONIC 3 0.0007
328 PULMONARY TUBERCULOSIS 3 0.0007
329 PURULENT DISCHARGE 3 0.0007
330 SKIN ATROPHY 4 0.0007
331 PNEUMOTHORAX 11 0.0007
332 HYSTERECTOMY 6 0.0007
333 PYELONEPHRITIS 6 0.0007
334 RESPIRATORY DISTRESS 19 0.0007
335 NEUTROPHIL COUNT DECREASED 28 0.0007
336 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 16 0.0007
337 GASTRITIS 18 0.0007
338 HYPOVOLAEMIA 4 0.0007
339 GINGIVAL SWELLING 3 0.0007
340 ABDOMINAL ABSCESS 3 0.0007
341 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
342 ARTHROPOD BITE 5 0.0007
343 CELLULITIS 34 0.0007
344 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
345 RHEUMATIC FEVER 3 0.0007
346 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 35 0.0007
347 METASTASES TO BONE 11 0.0007
348 HYDRONEPHROSIS 5 0.0007
349 GANGRENE 4 0.0007
350 END STAGE RENAL DISEASE 12 0.0007
351 INGUINAL HERNIA 4 0.0007
352 LUNG NEOPLASM MALIGNANT 27 0.0007
353 HYPONATRAEMIA 37 0.0007
354 CANDIDA INFECTION 11 0.0007
355 EYE OPERATION 3 0.0007
356 ASCITES 19 0.0006
357 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
358 INTERSTITIAL LUNG DISEASE 31 0.0006
359 SWELLING OF EYELID 4 0.0006
360 PRODUCT USE COMPLAINT 10 0.0006
361 DELIRIUM 22 0.0006
362 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
363 OEDEMA 34 0.0006
364 NON-SMALL CELL LUNG CANCER 3 0.0006
365 ORAL PAIN 14 0.0006
366 NEUTROPENIA 85 0.0006
367 HUMERUS FRACTURE 3 0.0006
368 HYPERCHOLESTEROLAEMIA 6 0.0006
369 ENTEROCOCCAL INFECTION 3 0.0006
370 RASH VESICULAR 3 0.0006
371 BLOOD POTASSIUM INCREASED 10 0.0006
372 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
373 RENAL CELL CARCINOMA 3 0.0006
374 GASTROOESOPHAGEAL REFLUX DISEASE 49 0.0006
375 BEDRIDDEN 8 0.0006
376 PULMONARY CONGESTION 8 0.0006
377 PERICARDIAL EFFUSION 14 0.0006
378 HAEMATOCRIT DECREASED 12 0.0006
379 C-REACTIVE PROTEIN INCREASED 22 0.0006
380 DIABETES MELLITUS 46 0.0006
381 ALANINE AMINOTRANSFERASE INCREASED 37 0.0006
382 ASPARTATE AMINOTRANSFERASE INCREASED 32 0.0006
383 PRESCRIBED UNDERDOSE 12 0.0006
384 FLUID INTAKE REDUCED 3 0.0006
385 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
386 ERYSIPELAS 3 0.0006
387 TOXIC SKIN ERUPTION 6 0.0006
388 KLEBSIELLA INFECTION 3 0.0006
389 CONJUNCTIVITIS 11 0.0006
390 METASTASES TO LYMPH NODES 4 0.0006
391 MUSCULOSKELETAL PAIN 31 0.0006
392 PATHOLOGICAL FRACTURE 3 0.0006
393 TACHYPNOEA 8 0.0006
394 HYPOPHAGIA 15 0.0006
395 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
396 EYE MOVEMENT DISORDER 4 0.0006
397 CEREBRAL ISCHAEMIA 3 0.0006
398 ACUTE MYELOID LEUKAEMIA 9 0.0006
399 LARGE INTESTINE POLYP 4 0.0006
400 THERAPY PARTIAL RESPONDER 9 0.0006
401 TRANSFUSION 6 0.0006
402 ACUTE RESPIRATORY FAILURE 11 0.0006
403 URINARY RETENTION 19 0.0006
404 CARDIOMEGALY 7 0.0006
405 TUMOUR LYSIS SYNDROME 5 0.0006
406 INCONTINENCE 6 0.0006
407 DUODENAL ULCER 4 0.0006
408 LUNG INFILTRATION 5 0.0006
409 ULCER 9 0.0006
410 ANORECTAL DISCOMFORT 3 0.0006
411 HEPATIC FAILURE 17 0.0006
412 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
413 FOOD POISONING 3 0.0006
414 OEDEMA PERIPHERAL 68 0.0006
415 ANAL ABSCESS 3 0.0006
416 WHEEZING 33 0.0006
417 ERYTHEMA OF EYELID 3 0.0006
418 VISUAL FIELD DEFECT 4 0.0006
419 DERMATITIS BULLOUS 4 0.0006
420 PNEUMONITIS 15 0.0006
421 FAECALOMA 3 0.0005
422 FLATULENCE 31 0.0005
423 MOUTH HAEMORRHAGE 4 0.0005
424 GASTROINTESTINAL PAIN 6 0.0005
425 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
426 BONE MARROW FAILURE 11 0.0005
427 HAEMOPTYSIS 15 0.0005
428 BLOOD UREA INCREASED 9 0.0005
429 PULMONARY MASS 8 0.0005
430 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
431 CEREBRAL INFARCTION 13 0.0005
432 SPINAL DISORDER 5 0.0005
433 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
434 TROPONIN INCREASED 4 0.0005
435 HAEMATURIA 18 0.0005
436 PAIN 322 0.0005
437 ACIDOSIS 4 0.0005
438 BOWEL MOVEMENT IRREGULARITY 4 0.0005
439 HYPERGLYCAEMIA 19 0.0005
440 HERPES VIRUS INFECTION 3 0.0005
441 EATING DISORDER 11 0.0005
442 HYPOGLYCAEMIA 25 0.0005
443 STAPHYLOCOCCAL INFECTION 17 0.0005
444 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
445 PULMONARY OEDEMA 23 0.0005
446 IRRITABLE BOWEL SYNDROME 11 0.0005
447 PNEUMONIA 166 0.0005
448 HAEMORRHAGIC STROKE 4 0.0005
449 SKIN FISSURES 10 0.0005
450 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
451 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
452 AFFECTIVE DISORDER 4 0.0005
453 BLOOD CREATININE INCREASED 33 0.0005
454 FURUNCLE 4 0.0005
455 CHOLECYSTITIS 6 0.0005
456 HYPOMAGNESAEMIA 7 0.0005
457 BLOOD TEST ABNORMAL 7 0.0005
458 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
459 LEUKOCYTOSIS 9 0.0005
460 PLATELET COUNT DECREASED 53 0.0005
461 MUCOSAL INFLAMMATION 13 0.0005
462 EMPHYSEMA 5 0.0005
463 STOMATITIS 30 0.0005
464 TASTE DISORDER 10 0.0005
465 INTENTIONAL PRODUCT MISUSE 43 0.0005
466 SUBARACHNOID HAEMORRHAGE 5 0.0005
467 SUBDURAL HAEMATOMA 7 0.0005
468 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
469 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
470 PIGMENTATION DISORDER 3 0.0005
471 POOR VENOUS ACCESS 5 0.0005
472 BACTERIAL INFECTION 9 0.0005
473 BACK PAIN 112 0.0005
474 INFUSION SITE SWELLING 3 0.0005
475 PROTEINURIA 9 0.0005
476 NAUSEA 372 0.0005
477 IMMUNODEFICIENCY 7 0.0005
478 MENTAL STATUS CHANGES 13 0.0005
479 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
480 DEMENTIA 13 0.0005
481 ERUCTATION 9 0.0005
482 OFF LABEL USE 404 0.0005
483 CHILLS 54 0.0005
484 SKIN LACERATION 5 0.0005
485 DEHYDRATION 61 0.0005
486 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
487 TOOTH INFECTION 6 0.0005
488 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
489 APPETITE DISORDER 3 0.0005
490 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
491 VENTRICULAR FIBRILLATION 5 0.0004
492 SKIN MASS 3 0.0004
493 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
494 PRODUCT ADMINISTRATION ERROR 9 0.0004
495 CYANOSIS 7 0.0004
496 PANCREATITIS ACUTE 10 0.0004
497 ANAL INCONTINENCE 4 0.0004
498 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
499 MITRAL VALVE INCOMPETENCE 5 0.0004
500 ABDOMINAL DISTENSION 46 0.0004
501 IMPAIRED GASTRIC EMPTYING 6 0.0004
502 ACUTE HEPATIC FAILURE 6 0.0004
503 ACUTE KIDNEY INJURY 67 0.0004
504 HERPES ZOSTER 25 0.0004
505 SHOCK 10 0.0004
506 RESPIRATORY DISORDER 13 0.0004
507 DROOLING 3 0.0004
508 WOUND 12 0.0004
509 DRUG INEFFECTIVE 565 0.0004
510 APPENDICITIS 4 0.0004
511 RIGHT VENTRICULAR FAILURE 3 0.0004
512 DEFORMITY 4 0.0004
513 VOMITING 201 0.0004
514 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0004
515 FLANK PAIN 4 0.0004
516 ANAPHYLACTIC SHOCK 11 0.0004
517 SKIN ULCER 11 0.0004
518 DYSPNOEA EXERTIONAL 16 0.0004
519 SINUS TACHYCARDIA 6 0.0004
520 DIVERTICULUM 3 0.0004
521 URINARY TRACT INFECTION 72 0.0004
522 DECREASED APPETITE 98 0.0004
523 BLOOD URINE PRESENT 8 0.0004
524 FUNGAL INFECTION 14 0.0004
525 ARTHRITIS 33 0.0004
526 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
527 CARDIOGENIC SHOCK 6 0.0004
528 IMPAIRED QUALITY OF LIFE 6 0.0004
529 LETHARGY 24 0.0004
530 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
531 FAECES SOFT 3 0.0004
532 RASH PUSTULAR 3 0.0004
533 PANCYTOPENIA 23 0.0004
534 AUTOIMMUNE DISORDER 4 0.0004
535 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
536 MELAENA 9 0.0004
537 CYTOPENIA 5 0.0004
538 ENCEPHALOPATHY 10 0.0004
539 HEPATOMEGALY 4 0.0004
540 RENAL FAILURE 54 0.0004
541 CARDIOMYOPATHY 6 0.0004
542 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
543 GENERALISED OEDEMA 5 0.0004
544 PHARYNGITIS 5 0.0004
545 TOOTH EXTRACTION 5 0.0004
546 ECZEMA 21 0.0004
547 HAEMOGLOBIN DECREASED 41 0.0004
548 BREAST TENDERNESS 3 0.0004
549 INTESTINAL OBSTRUCTION 15 0.0004
550 PAROSMIA 3 0.0004
551 IMPAIRED HEALING 13 0.0004
552 BRAIN OEDEMA 5 0.0004
553 LYMPHADENOPATHY 14 0.0004
554 FEELING COLD 11 0.0004
555 HYPOTHERMIA 4 0.0004
556 MUSCLE ATROPHY 5 0.0004
557 HEPATOCELLULAR CARCINOMA 3 0.0004
558 SLUGGISHNESS 4 0.0004
559 DIARRHOEA 252 0.0004
560 DIFFUSE LARGE B-CELL LYMPHOMA 3 0.0004
561 MUSCULOSKELETAL STIFFNESS 34 0.0004
562 APHTHOUS ULCER 3 0.0004
563 HIATUS HERNIA 5 0.0004
564 HYPERBILIRUBINAEMIA 4 0.0004
565 VENTRICULAR EXTRASYSTOLES 4 0.0004
566 RESPIRATORY TRACT INFECTION 10 0.0004
567 PETECHIAE 4 0.0004
568 WEIGHT FLUCTUATION 4 0.0004
569 SARS-COV-2 TEST POSITIVE 5 0.0004
570 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
571 FULL BLOOD COUNT ABNORMAL 4 0.0004
572 HEADACHE 237 0.0004
573 HYPERTENSION 80 0.0004
574 RENAL PAIN 4 0.0004
575 GINGIVAL PAIN 3 0.0004
576 ATRIAL FLUTTER 3 0.0004
577 JOINT INJURY 8 0.0004
578 CARDIAC FAILURE 30 0.0004
579 OXYGEN SATURATION DECREASED 21 0.0004
580 BREAST CANCER METASTATIC 4 0.0004
581 RHINITIS 3 0.0004
582 URINARY INCONTINENCE 11 0.0004
583 MUSCLE DISORDER 3 0.0004
584 FIBROMYALGIA 9 0.0004
585 HYPOCALCAEMIA 7 0.0004
586 CHRONIC KIDNEY DISEASE 28 0.0004
587 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
588 ABNORMAL FAECES 3 0.0004
589 HICCUPS 3 0.0004
590 SKIN LESION 10 0.0004
591 SEROTONIN SYNDROME 7 0.0004
592 PERIPHERAL COLDNESS 5 0.0004
593 SEIZURE 42 0.0004
594 CEREBRAL HAEMORRHAGE 13 0.0004
595 DENTAL CARIES 4 0.0004
596 CYTOMEGALOVIRUS INFECTION 6 0.0004
597 HEMIPLEGIA 3 0.0004
598 DRUG ABUSE 30 0.0004
599 EAR PAIN 7 0.0004
600 MASS 5 0.0004
601 RENAL IMPAIRMENT 30 0.0004
602 INTESTINAL PERFORATION 4 0.0004
603 STATUS EPILEPTICUS 4 0.0004
604 DYSURIA 13 0.0004
605 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
606 BLOOD PRESSURE ABNORMAL 7 0.0004
607 BRONCHITIS 26 0.0004
608 DRUG-INDUCED LIVER INJURY 11 0.0004
609 INTERNAL HAEMORRHAGE 4 0.0003
610 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
611 ANGINA PECTORIS 10 0.0003
612 THROMBOCYTOPENIA 39 0.0003
613 NEOPLASM 4 0.0003
614 GASTRIC HAEMORRHAGE 4 0.0003
615 MYOPATHY 3 0.0003
616 METASTASES TO LUNG 4 0.0003
617 HYPOKINESIA 5 0.0003
618 DEAFNESS 9 0.0003
619 BLOOD CALCIUM INCREASED 3 0.0003
620 NIGHT SWEATS 11 0.0003
621 DRY EYE 17 0.0003
622 ABDOMINAL DISCOMFORT 57 0.0003
623 GAIT DISTURBANCE 65 0.0003
624 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
625 HEAD DISCOMFORT 6 0.0003
626 DEEP VEIN THROMBOSIS 22 0.0003
627 PERITONITIS 7 0.0003
628 BLOOD IRON DECREASED 4 0.0003
629 PULMONARY HYPERTENSION 7 0.0003
630 HAEMOLYTIC ANAEMIA 3 0.0003
631 RASH ERYTHEMATOUS 16 0.0003
632 GASTROINTESTINAL INFECTION 3 0.0003
633 HAEMORRHAGE INTRACRANIAL 5 0.0003
634 PAIN OF SKIN 9 0.0003
635 TOOTHACHE 6 0.0003
636 OSTEOMYELITIS 6 0.0003
637 VIRAL INFECTION 11 0.0003
638 BURSITIS 4 0.0003
639 RETCHING 7 0.0003
640 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
641 MUSCLE SPASTICITY 4 0.0003
642 OVARIAN CANCER 3 0.0003
643 DIVERTICULITIS 9 0.0003
644 OSTEONECROSIS OF JAW 8 0.0003
645 INJECTION SITE DISCOLOURATION 4 0.0003
646 GENERAL PHYSICAL HEALTH DETERIORATION 37 0.0003
647 SECRETION DISCHARGE 4 0.0003
648 TRANSAMINASES INCREASED 7 0.0003
649 CYSTITIS 10 0.0003
650 INFLUENZA 35 0.0003
651 BURNING SENSATION 22 0.0003
652 ABSCESS 5 0.0003
653 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
654 SINUS BRADYCARDIA 3 0.0003
655 LIVER FUNCTION TEST ABNORMAL 9 0.0003
656 RHINORRHOEA 20 0.0003
657 DIZZINESS POSTURAL 3 0.0003
658 PARKINSONISM 3 0.0003
659 ORAL HERPES 6 0.0003
660 KIDNEY INFECTION 6 0.0003
661 SPEECH DISORDER 16 0.0003
662 HOSPICE CARE 3 0.0003
663 LIGAMENT SPRAIN 3 0.0003
664 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
665 BLOOD PRESSURE DECREASED 20 0.0003
666 COAGULOPATHY 5 0.0003
667 ATRIAL FIBRILLATION 29 0.0003
668 FACE OEDEMA 5 0.0003
669 FEEDING DISORDER 6 0.0003
670 DYSPHAGIA 28 0.0003
671 PALLOR 8 0.0003
672 MALIGNANT NEOPLASM PROGRESSION 30 0.0003
673 CONDITION AGGRAVATED 89 0.0003
674 OROPHARYNGEAL PAIN 27 0.0003
675 PSORIASIS 38 0.0003
676 FEMUR FRACTURE 9 0.0003
677 SKELETAL INJURY 3 0.0003
678 EYE DISCHARGE 3 0.0003
679 NERVOUS SYSTEM DISORDER 9 0.0003
680 NEURALGIA 7 0.0003
681 ASTHENIA 108 0.0003
682 ORTHOSTATIC HYPOTENSION 5 0.0003
683 CARDIAC FAILURE CONGESTIVE 23 0.0003
684 LIVER INJURY 7 0.0003
685 MOUTH ULCERATION 6 0.0003
686 METASTASES TO LIVER 5 0.0003
687 SKIN REACTION 4 0.0003
688 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
689 RASH 123 0.0003
690 METABOLIC ACIDOSIS 9 0.0003
691 TACHYCARDIA 25 0.0003
692 THIRST 5 0.0003
693 LIVER FUNCTION TEST INCREASED 6 0.0003
694 PARALYSIS 4 0.0003
695 COVID-19 49 0.0003
696 BLOOD CHOLESTEROL INCREASED 13 0.0003
697 CARDIAC ARREST 23 0.0003
698 PRURITUS GENERALISED 6 0.0003
699 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 50 0.0003
700 FAECES DISCOLOURED 6 0.0003
701 MYELODYSPLASTIC SYNDROME 4 0.0003
702 GASTRIC CANCER 7 0.0003
703 HYPERTHYROIDISM 4 0.0003
704 HAEMATEMESIS 7 0.0003
705 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
706 PANIC ATTACK 10 0.0003
707 APPLICATION SITE PAIN 6 0.0003
708 HAEMATOMA 7 0.0003
709 SKIN HAEMORRHAGE 4 0.0003
710 RASH MACULO-PAPULAR 6 0.0003
711 DIPLOPIA 7 0.0003
712 AGRANULOCYTOSIS 5 0.0003
713 EYE SWELLING 10 0.0003
714 COLON CANCER 4 0.0003
715 HEART RATE IRREGULAR 6 0.0003
716 APHASIA 8 0.0003
717 FALL 88 0.0003
718 MUSCULAR WEAKNESS 30 0.0003
719 MYOCARDIAL ISCHAEMIA 3 0.0003
720 OSTEOPENIA 4 0.0003
721 PRODUCT AVAILABILITY ISSUE 6 0.0003
722 SLEEP APNOEA SYNDROME 5 0.0003
723 EPILEPSY 8 0.0003
724 CHOLESTASIS 5 0.0003
725 GLAUCOMA 5 0.0003
726 HERNIA 5 0.0003
727 EYELID OEDEMA 3 0.0003
728 CHOKING 5 0.0003
729 HYPOTENSION 51 0.0003
730 EPISTAXIS 19 0.0003
731 PULMONARY EMBOLISM 24 0.0003
732 INFLAMMATION 13 0.0003
733 MYOCLONUS 3 0.0003
734 MUSCLE RIGIDITY 3 0.0003
735 SPINAL FRACTURE 5 0.0002
736 BLISTER 14 0.0002
737 SKIN EXFOLIATION 21 0.0002
738 INFECTION 36 0.0002
739 PANCREATITIS 13 0.0002
740 LUNG DISORDER 12 0.0002
741 HYPERSOMNIA 7 0.0002
742 RIB FRACTURE 5 0.0002
743 DRUG LEVEL INCREASED 4 0.0002
744 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
745 RHABDOMYOLYSIS 10 0.0002
746 POLLAKIURIA 10 0.0002
747 DERMATITIS ALLERGIC 3 0.0002
748 PRODUCT DOSE OMISSION ISSUE 70 0.0002
749 ACUTE MYOCARDIAL INFARCTION 7 0.0002
750 RENAL FAILURE ACUTE 10 0.0002
751 GENITAL HAEMORRHAGE 3 0.0002
752 CHEST PAIN 43 0.0002
753 MULTI-ORGAN FAILURE 4 0.0002
754 SEDATION 6 0.0002
755 NEUROTOXICITY 4 0.0002
756 AMENORRHOEA 4 0.0002
757 IMMUNE SYSTEM DISORDER 3 0.0002
758 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
759 BRADYCARDIA 12 0.0002
760 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
761 HAIR TEXTURE ABNORMAL 3 0.0002
762 MYELOSUPPRESSION 8 0.0002
763 BONE PAIN 13 0.0002
764 NEUROPATHY PERIPHERAL 21 0.0002
765 DISEASE PROGRESSION 26 0.0002
766 BONE DISORDER 4 0.0002
767 HYPOTHYROIDISM 7 0.0002
768 ARTHRALGIA 91 0.0002
769 LOSS OF CONSCIOUSNESS 28 0.0002
770 RESPIRATORY ARREST 6 0.0002
771 CONFUSIONAL STATE 35 0.0002
772 LACTIC ACIDOSIS 7 0.0002
773 MEDICATION ERROR 12 0.0002
774 ORAL DISCOMFORT 3 0.0002
775 CARDIO-RESPIRATORY ARREST 9 0.0002
776 RENAL DISORDER 10 0.0002
777 ABDOMINAL PAIN UPPER 44 0.0002
778 DEVICE OCCLUSION 3 0.0002
779 DYSARTHRIA 8 0.0002
780 BLOOD SODIUM DECREASED 4 0.0002
781 LYMPHOPENIA 3 0.0002
782 INTENTIONAL DOSE OMISSION 6 0.0002
783 BRONCHOSPASM 3 0.0002
784 DERMATITIS ATOPIC 11 0.0002
785 OVERDOSE 45 0.0002
786 BLOOD PRESSURE FLUCTUATION 5 0.0002
787 POST PROCEDURAL COMPLICATION 4 0.0002
788 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
789 PRESCRIBED OVERDOSE 4 0.0002
790 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
791 RENAL INJURY 6 0.0002
792 SINUS DISORDER 4 0.0002
793 DISORIENTATION 8 0.0002
794 CATARACT 12 0.0002
795 THERAPY NON-RESPONDER 9 0.0002
796 SYNCOPE 20 0.0002
797 BLOOD POTASSIUM DECREASED 6 0.0002
798 HYPOAESTHESIA ORAL 3 0.0002
799 DEVICE FAILURE 3 0.0002
800 DYSKINESIA 8 0.0002
801 DISCOMFORT 12 0.0002
802 NEPHROLITHIASIS 9 0.0002
803 INSOMNIA 52 0.0002
804 NEOPLASM MALIGNANT 13 0.0002
805 ERECTILE DYSFUNCTION 5 0.0002
806 UNDERDOSE 14 0.0002
807 PRURITUS 73 0.0002
808 NASOPHARYNGITIS 35 0.0002
809 GASTROINTESTINAL DISORDER 17 0.0002
810 HALLUCINATION, VISUAL 4 0.0002
811 RESPIRATORY TRACT CONGESTION 3 0.0002
812 SOMNOLENCE 38 0.0002
813 MYALGIA 32 0.0002
814 FLUSHING 19 0.0002
815 HIP FRACTURE 6 0.0002
816 JAUNDICE 5 0.0002
817 HOT FLUSH 14 0.0002
818 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
819 PRODUCT PRESCRIBING ISSUE 4 0.0002
820 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
821 MOBILITY DECREASED 13 0.0002
822 PRODUCT USE ISSUE 34 0.0002
823 LIP SWELLING 6 0.0002
824 TOOTH DISORDER 4 0.0002
825 FEELING HOT 11 0.0002
826 HYPERHIDROSIS 23 0.0002
827 SNEEZING 4 0.0002
828 MIGRAINE 17 0.0002
829 DYSPNOEA 100 0.0002
830 BLOOD PRESSURE INCREASED 27 0.0002
831 PAIN IN JAW 5 0.0002
832 DRUG INTOLERANCE 17 0.0002
833 SINUSITIS 18 0.0002
834 PERIPHERAL SWELLING 27 0.0002
835 SCAR 3 0.0002
836 RED BLOOD CELL COUNT DECREASED 5 0.0002
837 COUGH 49 0.0002
838 ILLNESS 18 0.0002
839 TREMOR 29 0.0002
840 MUSCULOSKELETAL DISCOMFORT 3 0.0002
841 DRUG DEPENDENCE 28 0.0002
842 TINNITUS 8 0.0002
843 EYE IRRITATION 10 0.0002
844 MUSCLE TWITCHING 4 0.0002
845 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
846 NEEDLE ISSUE 5 0.0002
847 HEART RATE INCREASED 17 0.0002
848 EOSINOPHILIA 3 0.0002
849 SLEEP DISORDER 12 0.0002
850 PRODUCT USE IN UNAPPROVED INDICATION 42 0.0002
851 VISUAL IMPAIRMENT 21 0.0002
852 LABORATORY TEST ABNORMAL 5 0.0002
853 SWELLING FACE 11 0.0002
854 ARRHYTHMIA 8 0.0002
855 PRODUCTIVE COUGH 8 0.0002
856 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
857 FATIGUE 129 0.0002
858 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
859 CORONARY ARTERY DISEASE 5 0.0002
860 ACCIDENTAL OVERDOSE 6 0.0002
861 MUSCLE SPASMS 30 0.0002
862 HAEMORRHAGE 17 0.0002
863 CARDIAC DISORDER 15 0.0002
864 EYE PAIN 9 0.0002
865 ASTHMA 18 0.0002
866 FRACTURE 3 0.0002
867 ANGIOEDEMA 7 0.0002
868 DRUG INTERACTION 25 0.0002
869 HEPATITIS 4 0.0002
870 PAIN IN EXTREMITY 46 0.0002
871 CONTUSION 15 0.0002
872 DYSTONIA 3 0.0002
873 RASH GENERALISED 4 0.0002
874 APPLICATION SITE ERYTHEMA 4 0.0002
875 BALANCE DISORDER 13 0.0002
876 AGITATION 11 0.0001
877 HOSPITALISATION 23 0.0001
878 GAIT INABILITY 5 0.0001
879 SWELLING 14 0.0001
880 URTICARIA 25 0.0001
881 FULL BLOOD COUNT DECREASED 3 0.0001
882 EYE PRURITUS 5 0.0001
883 DIZZINESS 74 0.0001
884 DISTURBANCE IN ATTENTION 8 0.0001
885 ILL-DEFINED DISORDER 9 0.0001
886 DYSGEUSIA 11 0.0001
887 ALOPECIA 29 0.0001
888 COMA 7 0.0001
889 PRODUCT PREPARATION ERROR 3 0.0001
890 HALLUCINATION 11 0.0001
891 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
892 MEMORY IMPAIRMENT 20 0.0001
893 NECK PAIN 8 0.0001
894 WEIGHT INCREASED 32 0.0001
895 HEART RATE DECREASED 5 0.0001
896 FEELING ABNORMAL 34 0.0001
897 HYPERSENSITIVITY 26 0.0001
898 LEUKOPENIA 7 0.0001
899 CONVULSION 8 0.0001
900 HYPOACUSIS 6 0.0001
901 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
902 MENTAL DISORDER 6 0.0001
903 FLUID RETENTION 7 0.0001
904 CHEST DISCOMFORT 14 0.0001
905 SURGERY 8 0.0001
906 DEPRESSION 31 0.0001
907 DRY MOUTH 11 0.0001
908 INJECTION SITE MASS 5 0.0001
909 DRY SKIN 18 0.0001
910 GLOSSODYNIA 3 0.0001
911 CHROMATURIA 3 0.0001
912 BLOOD GLUCOSE INCREASED 25 0.0001
913 DEPRESSED MOOD 7 0.0001
914 THERAPEUTIC RESPONSE DECREASED 8 0.0001
915 VERTIGO 8 0.0001
916 VISION BLURRED 18 0.0001
917 SKIN IRRITATION 6 0.0001
918 SKIN DISCOLOURATION 6 0.0001
919 RASH PRURITIC 7 0.0001
920 COGNITIVE DISORDER 6 0.0001
921 ANAPHYLACTIC REACTION 7 0.0001
922 OCULAR HYPERAEMIA 6 0.0001
923 DISEASE RECURRENCE 6 0.0001
924 PRODUCT PRESCRIBING ERROR 3 0.0001
925 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
926 DIABETIC KETOACIDOSIS 3 0.0001
927 LOCALISED INFECTION 3 0.0001
928 ANXIETY 35 0.0001
929 BLINDNESS 5 0.0001
930 EYE DISORDER 4 0.0001
931 EXPIRED PRODUCT ADMINISTERED 4 0.0001
932 AGEUSIA 3 0.0001
933 HYPOAESTHESIA 18 0.0001
934 ROAD TRAFFIC ACCIDENT 5 0.0001
935 WITHDRAWAL SYNDROME 5 0.0001
936 ABDOMINAL PAIN LOWER 3 0.0001
937 DEVICE LEAKAGE 5 0.0001
938 NEOPLASM PROGRESSION 4 0.0001
939 DEVICE DISLOCATION 5 0.0001
940 PARAESTHESIA 18 0.0001
941 ANHEDONIA 3 0.0001
942 EAR INFECTION 3 0.0001
943 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
944 ACNE 8 0.0001
945 MYOCARDIAL INFARCTION 18 0.0001
946 DYSPHONIA 6 0.0001
947 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
948 INJECTION SITE REACTION 7 0.0001
949 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
950 ABNORMAL BEHAVIOUR 4 0.0001
951 LACRIMATION INCREASED 3 0.0001
952 THERAPY INTERRUPTED 7 0.0001
953 DRUG ADMINISTRATION ERROR 3 0.0001
954 SKIN BURNING SENSATION 7 0.0001
955 EMOTIONAL DISORDER 3 0.0001
956 CEREBROVASCULAR ACCIDENT 16 0.0001
957 EMOTIONAL DISTRESS 11 0.0001
958 DEATH 76 0.0001
959 GASTRIC DISORDER 3 0.0001
960 THROMBOSIS 7 0.0001
961 NASAL CONGESTION 5 0.0001
962 BLOOD GLUCOSE DECREASED 4 0.0001
963 IRRITABILITY 5 0.0001
964 TOXICITY TO VARIOUS AGENTS 14 0.0001
965 DRUG EFFECT INCOMPLETE 3 0.0001
966 RESTLESSNESS 3 0.0001
967 EXPOSURE DURING PREGNANCY 5 0.0001
968 AGGRESSION 4 0.0001
969 RHEUMATOID ARTHRITIS 9 0.0001
970 PLASMA CELL MYELOMA 3 0.0001
971 PALPITATIONS 9 0.0001
972 NERVOUSNESS 4 0.0001
973 BREAST CANCER 7 0.0001
974 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
975 TREATMENT FAILURE 6 0.0001
976 INJECTION SITE PAIN 22 0.0001
977 JOINT SWELLING 8 0.0001
978 UNEVALUABLE EVENT 5 0.0001
979 AMNESIA 4 0.0001
980 PRODUCT QUALITY ISSUE 8 0.0001
981 DRUG WITHDRAWAL SYNDROME 5 0.0001
982 ADVERSE EVENT 5 0.0001
983 PRODUCT SUBSTITUTION ISSUE 3 0.0001
984 INJECTION SITE ERYTHEMA 6 0.0000
985 DEVICE ISSUE 4 0.0000
986 INCORRECT DOSE ADMINISTERED 10 0.0000
987 DEVICE MALFUNCTION 3 0.0000
988 INJURY 3 0.0000
989 INJECTION SITE SWELLING 3 0.0000
990 PROSTATE CANCER 3 0.0000
991 COMPLETED SUICIDE 3 0.0000
992 DRUG DOSE OMISSION 5 0.0000
993 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
994 NO ADVERSE EVENT 5 0.0000